A detailed history of Smartleaf Asset Management LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 1,267 shares of SUPN stock, worth $49,552. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,267
Previous 397 219.14%
Holding current value
$49,552
Previous $12.2 Million 283.09%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 05, 2025

BUY
$31.89 - $37.83 $27,744 - $32,912
870 Added 219.14%
1,267 $46.8 Million
Q3 2024

Nov 13, 2024

BUY
$25.77 - $35.16 $5,050 - $6,891
196 Added 97.51%
397 $12.2 Million
Q2 2024

Aug 13, 2024

BUY
$25.99 - $33.85 $5,223 - $6,803
201 New
201 $5.4 Million

Others Institutions Holding SUPN

About SUPERNUS PHARMACEUTICALS, INC.


  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $2.09B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Smartleaf Asset Management LLC Portfolio

Follow Smartleaf Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smartleaf Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Smartleaf Asset Management LLC with notifications on news.